Katerzia(TM), the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older

WOBURN, Mass., Sept. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today ... Biopharmaceuticals, Product Launch Azurity Pharmaceuticals, Katerzia, amlodipine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news